• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于零级持续释放的明胶微丸修饰

Modification of gelatin beadlets for zero-order sustained release.

作者信息

Chiao C S, Price J C

机构信息

School of Pharmacy, Northeast Louisiana University, Monroe 71209.

出版信息

Pharm Res. 1989 Jun;6(6):517-20. doi: 10.1023/a:1015980809952.

DOI:10.1023/a:1015980809952
PMID:2762229
Abstract

A three-phase suspension process was used for the preparation of gelatin beadlets containing succinylsulfathiazole. When the beadlets were hardened with 10% formalin at 5 degrees C for varying periods of time up to 24 hr, the 6-hr hardening time gave the slowest release rate. Drug release rate from gelatin beadlets was slower in simulated gastric fluid (SGF) than in simulated intestinal fluid (SIF) but the sustained effect was too limited to be useful for most applications. When the hardened gelatin beadlets were coated with cellulose acetate butyrate (CAB) by an emulsion-solvent evaporation method, a more pronounced sustained effect and a nearly zero-order release were found in SIF. The effects of the amount of gelatin used, the amount of CAB employed, and the length of hardening time on drug release were investigated. The treatment of gelatin beadlets with formalin reduced the swelling action of gelatin in aqueous medium. A nonzero-order drug release rate was observed when the gelatin swelled sufficiently to rupture the CAB coating. The drug release rate can be adjusted by using different ratios of hardened gelatin beadlets and CAB coating in which the gelatin enhances the release rate and the CAB serves as a barrier.

摘要

采用三相悬浮法制备含琥珀酰磺胺噻唑的明胶微丸。当微丸在5℃下用10%甲醛硬化不同时间(最长24小时)时,6小时的硬化时间释放速率最慢。明胶微丸在模拟胃液(SGF)中的药物释放速率比在模拟肠液(SIF)中慢,但持续效果过于有限,对大多数应用来说并无用处。当通过乳液 - 溶剂蒸发法用醋酸丁酸纤维素(CAB)包衣硬化后的明胶微丸时,在SIF中发现了更显著的持续效果和近乎零级的释放。研究了明胶用量、CAB用量和硬化时间长度对药物释放的影响。用甲醛处理明胶微丸降低了明胶在水性介质中的溶胀作用。当明胶充分溶胀以破裂CAB包衣时,观察到非零级药物释放速率。通过使用不同比例的硬化明胶微丸和CAB包衣可以调节药物释放速率,其中明胶提高释放速率,而CAB起到屏障作用。

相似文献

1
Modification of gelatin beadlets for zero-order sustained release.用于零级持续释放的明胶微丸修饰
Pharm Res. 1989 Jun;6(6):517-20. doi: 10.1023/a:1015980809952.
2
A new approach in gastroretentive drug delivery system using cholestyramine.一种使用消胆胺的胃滞留药物递送系统的新方法。
Drug Deliv. 2003 Jul-Sep;10(3):151-60. doi: 10.1080/713840399.
3
Formulation parameters affecting the performance of coated gelatin capsules with pulsatile release profiles.影响具有脉冲释放特性的包衣明胶胶囊性能的制剂参数。
Int J Pharm. 2003 Nov 28;267(1-2):59-68. doi: 10.1016/j.ijpharm.2003.07.008.
4
Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release system.含有葡聚糖离子交换树脂的醋酸丁酸纤维素微胶囊作为自推进式药物释放系统。
Biomaterials. 2005 Jul;26(20):4337-47. doi: 10.1016/j.biomaterials.2004.10.036.
5
Release profile comparison and stability of diltiazem-resin microcapsules in sustained release suspensions.缓释混悬液中地尔硫䓬-树脂微胶囊的释放曲线比较及稳定性
Int J Pharm. 2008 Mar 20;352(1-2):81-91. doi: 10.1016/j.ijpharm.2007.10.018. Epub 2007 Oct 23.
6
Design of a slow-release capsule using laser drilling.
J Pharm Sci. 1984 Dec;73(12):1806-11. doi: 10.1002/jps.2600731237.
7
Controlled release of nifedipine from gelatin microspheres and microcapsules: in vitro kinetics and pharmacokinetics in man.硝苯地平从明胶微球和微囊中缓释:体外动力学及人体药代动力学
J Microencapsul. 1990 Apr-Jun;7(2):209-17. doi: 10.3109/02652049009021834.
8
Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine.研制硝苯地平新型喷涂包衣软质弹性明胶胶囊控释制剂。
Drug Dev Ind Pharm. 2009 Aug;35(8):1009-21. doi: 10.1080/03639040902725182.
9
Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release.硬明胶卡马西平胶囊的交联:溶出条件对体外药物释放的影响。
Eur J Pharm Sci. 2003 Jun;19(2-3):129-32. doi: 10.1016/s0928-0987(03)00070-8.
10
Formulation, preparation and dissolution characteristics of propranolol hydrochloride microspheres.盐酸普萘洛尔微球的处方、制备及溶出特性
J Microencapsul. 1994 Mar-Apr;11(2):153-9. doi: 10.3109/02652049409040446.

引用本文的文献

1
Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole.
Pharm Res. 1992 Mar;9(3):390-7. doi: 10.1023/a:1015803321609.

本文引用的文献

1
A new oral gelatinized sustained-release dosage form.
J Pharm Sci. 1963 Jul;52:664-7. doi: 10.1002/jps.2600520714.
2
Preparation and evaluation of gelatin microcapsules of sulfonamides.
Chem Pharm Bull (Tokyo). 1983 Jan;31(1):256-61. doi: 10.1248/cpb.31.256.
3
Gelatin encapsulation pharmaceuticals.
J Clin Pharmacol J New Drugs. 1968 Jan-Feb;8(1):54-9.
4
In vitro release of phenobarbitone from gelatin micropellets. Effect of pH of preparation.
Acta Pharm Suec. 1971 Sep;8(4):423-30.
5
Microencapsulation.
J Pharm Sci. 1970 Oct;59(10):1367-76. doi: 10.1002/jps.2600591002.
6
Gelatin coacervate microcapsules containing sulphamerazine: their preparation and the in vitro release of the drug.
J Pharm Pharmacol. 1968 Jul;20(7):528-38. doi: 10.1111/j.2042-7158.1968.tb09801.x.
7
Clofibrate microcapsules: preparation and release rat studies.
J Pharm Sci. 1976 Oct;65(10):1476-9.